Doheny Asset Management /Ca Amgen Inc Transaction History

Doheny Asset Management /Ca

$122 Million
Q1 2024

A detailed history of Doheny Asset Management /Ca transactions in Amgen Inc stock. As of the latest transaction made, Doheny Asset Management /Ca holds 1,955 shares of AMGN stock, worth $654,631. This represents 0.46% of its overall portfolio holdings.

Number of Shares

1,955

Previous 2,005 2.49%

Holding current value

$654,631

Previous $577,000 3.64%

% of portfolio

0.46%

Previous 0.57%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $13,443 - $16,228	-50 Reduced 2.49%	1,955 $556,000
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $109,325 - $135,730	-500 Reduced 19.96%	2,005 $539,000
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $56,447 - $68,800	250 Added 11.09%	2,505 $606,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $80,160 - $101,853	-350 Reduced 13.44%	2,255 $592,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $22,446 - $25,315	100 Added 3.99%	2,605 $587,000

Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $65,781 - $72,771	-300 Reduced 10.7%	2,505 $606,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $3,977 - $4,552	-20 Reduced 0.71%	2,805 $631,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $135,476 - $150,301	-580 Reduced 17.03%	2,825 $689,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $26,629 - $31,032	-120 Reduced 3.4%	3,405 $847,000
Q4 2020 Feb 26, 2021	SELL	$216.38 - $257.67 $117,061 - $139,399	-541 Reduced 13.31%	3,525 $810,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Reduced 5.27%	3,596 $914,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $110,285 - $122,646	470 Added 13.07%	4,066 $980,000
Q2 2020 Aug 18, 2020	SELL	$197.81 - $242.74 $53,408 - $65,539	-270 Reduced 6.64%	3,796 $895,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $28,381 - $36,480	-150 Reduced 3.56%	4,066 $980,000
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $519,718 - $622,730	-2,985 Reduced 41.45%	4,216 $816,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $465,092 - $545,193	2,790 Added 63.25%	7,201 $1.33 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $385,344 - $449,820	-2,160 Reduced 32.87%	4,411 $859,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $132,840 - $149,208	-800 Reduced 10.85%	6,571 $1.21 Million
Q1 2018 May 17, 2018	SELL	$169.43 - $198.0 $50,829 - $59,400	-300 Reduced 3.91%	7,371 $1.26 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $17,722 - $19,801	105 Added 1.39%	7,671 $1.33 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.27 Million - $1.45 Million	7,566	7,566 $1.41 Million

Others Institutions Holding AMGN

# of Institutions

2,975

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.61M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $179B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.

Account

Doheny Asset Management /Ca Amgen Inc Transaction History